Shire is a global leader in the development and manufacturing of therapies for bleeding conditions such as haemophilia. Shire has a decades-long heritage of innovation in the haemophilia community. We aim to develop a deep understanding of patients' needs to deliver transformative and personalised therapies intended to improve the lives of patients with haemophilia and other bleeding conditions.
Because people with haemophilia and other bleeding conditions are at the center of everything we do, Shire works with advocacy groups in communities around the world to expand access to treatments and improve the standards of care.
At Shire, we believe in a world with endless possibilities for patients, where they can dream big and live life to the fullest.
Relentless in our vision of a bleed-free future
Shire has been a dedicated partner to the haemophilia community. We have built our experience in haemophilia and are now expanding into other bleeding conditions.
Shire has a vision of a life without bleeds and aspires to make this a reality by continuing to bring innovative treatment options to the bleeding conditions community.